Hypoxia and the extracellular matrix: drivers of tumour metastasis
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fi broblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recently published literature discusses the role of the size of a tumor (and the associated hypoxia levels) on its aggressiveness [81,82,83,84,85] and on the efficacy of drug delivery to it [84,86,87].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Items 101–200 of 1,001
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
“By modulating collagen synthesis and collagen fiber alignment as well as integrin-ECM interactions within the TME, HIF-1α also aid tumor cell migration and metastasis [246,247].”
BackgroundLiu, Y., Niu, R., Zhao, H. Q., Wang, Y., Song, S., Zhang, H., & Zhao, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08622 · Cited by 151
Incio, J., Suboj, P., Chin, S. M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I., Deshpande, V., Jain, R. K., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141392 · Cited by 144
Wang, S.-B., Chen, Z.-X., Gao, F., Zhang, C., Zou, M.-Z., Ye, J.-J., Zeng, X., & Zhang, X.-Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119772 · Cited by 143
Raman Spectroscopy: Guiding Light for the Extracellular Matrix
Bergholt, M. S., Serio, A., & Albro, M. B. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00303 · Cited by 160
“, lung (White, 2015), kidney (Duffield, 2014), heart (Prabhu and Frangogiannis, 2016), and liver (Kisseleva, 2017)], (ii) musculoskeletal tissue degeneration from the break-down of the load-supporting ECM (Krishnan and Grodzinsky, 2018), and (iii) metastatic cancers from the invasion of malignant cells through ECM bar…”
BackgroundSormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 141
Wang, R., Wang, C., Lu, L., Yuan, F., & He, F. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107032 · Cited by 161
A Versatile Pt‐Based Core–Shell Nanoplatform as a Nanofactory for Enhanced Tumor Therapy
Wang, X., Zeng, J., Zhang, M., Zeng, X., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801783 · Cited by 138
Cell softness regulates tumorigenicity and stemness of cancer cells
Lv, J., Liu, Y., Cheng, F., Li, J., Zhou, Y., Zhang, T., Zhou, N., Li, C., Wang, Z., Ma, L., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020106123 · Cited by 152
“It is known that hypoxia in primary tumors is associated with an increased metastasis and a worse prognosis in patients with cancer (Erler et al , 2006; Gilkes et al , 2014; Rankin & Giaccia, 2016).”
Schwörer, S., Cimino, F. V., Ros, M., Tsanov, K. M., Ng, C., Lowe, S. W., Carmona‐Fontaine, C., & Thompson, C. B. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2316 · Cited by 160
Tumor microenvironment-mediated chemoresistance in breast cancer
velaei, K., Samadi, N., Barazvan, B., & Soleimani Rad, J. (2016) · The Breast · doi:10.1016/j.breast.2016.09.002 · Cited by 138
Amelio, I., Mancini, M., Petrova, V., Cairns, R. A., Vikhreva, P., Nicolai, S., Marini, A., Antonov, A. A., Le Quesne, J., Baena Acevedo, J. D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808314115 · Cited by 139
Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer
Chipurupalli, S., Kannan, E., Tergaonkar, V., D’Andrea, R. J., & Robinson, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030749 · Cited by 161
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 139
Evolution of cellular morpho-phenotypes in cancer metastasis.
Wu, P.-H., Phillip, J. M., Khatau, S. B., Chen, W.-C., Stirman, J., Rosseel, S., Tschudi, K., Van Patten, J., Wong, M., Gupta, S., et al. (2015) · Scientific Reports · doi:10.1038/srep18437 · Cited by 117
Self-citationCollagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
Natarajan, S., Foreman, K. M., Soriano, M. I., Rossen, N. S., Shehade, H., Fregoso, D. R., Eggold, J. T., Krishnan, V., Dorigo, O., Krieg, A. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2616 · Cited by 129
Prolyl and lysyl hydroxylases in collagen synthesis
Salo, A. M., & Myllyharju, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14197 · Cited by 151
Membrane-type matrix metalloproteases as diverse effectors of cancer progression
Turunen, S. P., Tatti-Bugaeva, O., & Lehti, K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.002 · Cited by 154
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Zhong, S., Jeong, J.-H., Chen, Z., Chen, Z., & Luo, J.-L. (2020) · Translational Oncology · doi:10.1016/j.tranon.2019.10.001 · Cited by 134
“TME is an essential part of the tumor mass, which is important for tumor growth, progression, metastasis, and therapy resistance [4,6,8].”
BackgroundBigos, K. J. A., Quiles, C. G., Lunj, S., Smith, D. J., Krause, M., Troost, E. G. C., West, C., Hoskin, P., & Choudhury, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1331355 · Cited by 166
“Hypoxia enhances ECM remodelling as a driver of tumour desmoplasia, a complex process that includes ECM degradation, composition and structural changes, generating a fi brotic and stiffer ECM (129).”
BackgroundHypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Belisario, D. C., Kopecka, J., Pasino, M., Akman, M., De Smaele, E., Donadelli, M., & Riganti, C. (2020) · Cells · doi:10.3390/cells9122598 · Cited by 133
“, by stimulating the paracrine secretion of soluble factors that generate a fibrotic and stiff ECM, favorable to cell spreading [19,20].”
BackgroundYeong, J. P.-S., Thike, A. A., Lim, J. C. T., Lee, B. T. K., Li, H., Wong, S. C., Hue, S. S., Tan, P. H., & Iqbal, J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4161-4 · Cited by 148
The role of type II transmembrane serine protease‐mediated signaling in cancer
Tanabe, L. M., & List, K. (2016) · FEBS Journal · doi:10.1111/febs.13971 · Cited by 132
Function of cancer cell-derived extracellular matrix in tumor progression
Xiong, G.-F., & Xu, R. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.08 · Cited by 128
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Farina, A. R., Cappabianca, L. A., Sebastiano, M., Zelli, V., Guadagni, S., & Mackay, A. R. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01616-9 · Cited by 145
Ju, J. A., Godet, I., Ye, I. C., Byun, J., Jayatilaka, H., Lee, S. J., Xiang, L., Samanta, D., Lee, M., Wu, P.-H., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0338 · Cited by 143
Self-citationHypoxic tumor microenvironment: Implications for cancer therapy
Roy, S., Kumaravel, S., Sharma, A., Duran, C. L., Bayless, K. J., & Chakraborty, S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220934038 · Cited by 141
“Hypoxia affects ECM through fibrosis, regulating collagen deposition and by mediating ECM degradation.(54) HIF-1a-mediated fibrosis enhances cell invasion and migration by increased ECM deposition.”
BackgroundIntratumoral oxygen gradients mediate sarcoma cell invasion
Lewis, D. M., Park, K. M., Tang, V., Xu, Y., Pak, K., Eisinger-Mathason, T. S. K., Simon, M. C., & Gerecht, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605317113 · Cited by 125
Yu, M., Duan, X., Cai, Y., Zhang, F., Jiang, S., Han, S., Shen, J., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201900037 · Cited by 129
Cancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 132
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 120
Metal–Drug Coordination Nanoparticles and Hydrogels for Enhanced Delivery
Wong, K., Nie, Z., Wong, M., Wang, Y., & Liu, J. (2024) · Advanced Materials · doi:10.1002/adma.202404053 · Cited by 131
van Rixel, V. H. S., Ramu, V., Auyeung, A. B., Beztsinna, N., Leger, D. Y., Lameijer, L. N., Hilt, S. T., Dévédec, S. E. L., Yıldız, T., Betancourt, T., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b07225 · Cited by 117
Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture
Ryan, S.-L., Baird, A.-M., Vaz, G., Urquhart, A. J., Senge, H., Richard, D. J., O'Byrne, K. J., & Davies, A. M. (2016) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2015.670 · Cited by 118
Musah-Eroje, A., & Watson, S. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03107-0 · Cited by 126
Li, Y., Sun, P., Zhao, L., Yan, X., Ng, D. K. P., & Lo, P. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010005 · Cited by 121
An NIR‐II Photothermally Triggered “Oxygen Bomb” for Hypoxic Tumor Programmed Cascade Therapy
Zhang, S., Li, Z., Wang, Q., Liu, Q., Yuan, W., Feng, W., & Li, F. (2022) · Advanced Materials · doi:10.1002/adma.202201978 · Cited by 118
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
Hernandez-Fernaud, J. R., Ruengeler, E., Casazza, A., Neilson, L. J., Pulleine, E., Santi, A., Ismail, S., Lilla, S., Dhayade, S., Macpherson, I. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14206 · Cited by 128
EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
Tsai, W.-H., Yu, K.-H., Huang, Y., & Lee, C.-I. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s148305 · Cited by 120
Oncolytic viruses: overcoming translational challenges
Martínez‐Quintanilla, J., Seah, I. Y. J., Chua, M. M. J., & Shah, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122287 · Cited by 130
Yang, G., Tian, J. H., Chen, C., Jiang, D., Xue, Y., Wang, C., Gao, Y., & Zhang, W. (2019) · Chemical Science · doi:10.1039/c9sc00985j · Cited by 118
Roles of mitochondria in the hallmarks of metastasis
Scheid, A. D., Beadnell, T. C., & Welch, D. R. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01125-8 · Cited by 137
Cai, J., Xia, L., Li, J., Ni, S., Song, H., & Wu, X. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2017.613 · Cited by 115
Du, F., Chen, J., Liu, H., Cai, Y., Cao, T., Han, W., Yi, X., Qian, M., Tian, D., Nie, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1481-9 · Cited by 122
Chandran, V. I., Welinder, C., Månsson, A., Offer, S., Freyhult, E., Pernemalm, M., Lund, S. M., Pedersen, S., Lehtiö, J., Marko‐Varga, G., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2946 · Cited by 120
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
Phung, C. D., Tran, T. H., Pham, L. M., Nguyen, H. T., Jeong, J., Yong, C. S., & Kim, J. O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.029 · Cited by 115
Structural ECM components in the premetastatic and metastatic niche
Høye, A. M., & Erler, J. T. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00326.2015 · Cited by 114
Adaptive Stress Responses During Tumor Metastasis and Dormancy
Senft, D., & Ronai, Z. A. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.06.004 · Cited by 123
LOXL2 in cancer: regulation, downstream effectors and novel roles
Wen, B., Xu, L., & Li, E. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188435 · Cited by 123
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Chen, Q., Sun, T., & Jiang, C. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00622-6 · Cited by 124
Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions
Welch, D. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3024 · Cited by 118
Krisnawan, V. E., Stanley, J. A., Schwarz, J. K., & DeNardo, D. G. (2020) · Cancers · doi:10.3390/cancers12102916 · Cited by 122
“As detailed earlier, angiogenesis is one factor that contributes to tumor cell radioresistance [8].”
BackgroundInfluentialA core matrisome gene signature predicts cancer outcome
Yuzhalin, A. E., Urbonas, T., Silva, M. A., Muschel, R. J., & Gordon-Weeks, A. N. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.458 · Cited by 113
Jiang, W., Li, Q., Xiao, L., Dou, J., Liu, Y., Yu, W., Ma, Y., Li, X., You, Y.-Z., Tong, Z., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01508 · Cited by 109
Liu, Y., Zhu, P., Wang, Y., Wei, Z., Li, T., Zhu, Z., Sheng, X., Wang, S., Ruan, J., Liu, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123781 · Cited by 109
The Different Routes to Metastasis via Hypoxia-Regulated Programs
Nobre, A. R., Entenberg, D. R., Wang, Y., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.008 · Cited by 111
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
Yang, P., Markowitz, G. J., & Wang, X. (2014) · National Science Review · doi:10.1093/nsr/nwu038 · Cited by 119
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
Eckert, A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., & Seliger, B. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0828-6 · Cited by 118
Zhang, F., Liu, H., Duan, M., Wang, G., Zhang, Z., Wang, Y., Qian, Y., Yang, Z., & Jiang, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01304-5 · Cited by 126
Dual-targeted photothermal agents for enhanced cancer therapy
Wang, K., Xiang, Y., Pan, W., Wang, H., Li, N., & Tang, B. (2020) · Chemical Science · doi:10.1039/d0sc03173a · Cited by 109
Du, H., Pang, M., Hou, X., Yuan, S., & Sun, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.023 · Cited by 122
Wang, T., Zhang, H., Qiu, W., Han, Y., Liu, H., & Li, Z. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.12.029 · Cited by 104
“the polarization of macrophages into M2-like TAMs to suppress immune responses, relieving the hypoxia through advanced nanoparticles has become an important strategy to reprogram M2-like TAMs into M1 phenotype for improving immunotherapy [12,13], which has been”
BackgroundHypoxia: molecular pathophysiological mechanisms in human diseases
Rocca, Y. D., Fonticoli, L., Rajan, T. S., Trubiani, O., Caputi, S., Diomede, F., Pizzicannella, J., & Marconi, G. D. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00912-6 · Cited by 135
“These metalloproteinases are upregulated by hypoxia in breast and colon cancer cells via HIF1-dependent mechanism, while type 1 MMP, also known as MMP14, exhibits HIF2dependent upregulation [34].”
BackgroundInfluentialNg, S., Tan, W. J., Pek, M. M. X., Tan, M.-H., & Kurisawa, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119400 · Cited by 105
Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype
Hill, B. S., Pelagalli, A., Passaro, N., & Zannetti, A. (2017) · Oncotarget · doi:10.18632/oncotarget.20265 · Cited by 104
Xu, F., Zhang, J., Hu, G., Liu, L., & Liang, W. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0420-z · Cited by 111
Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic/Biotic Nanoparticles
Zheng, D., Li, B., Xu, L., Zhang, Q.-L., Fan, J.-X., Li, C.-X., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b02977 · Cited by 103
Wang, Z., Gong, X., Li, J., Wang, H., Xu, X., Li, Y., Sha, X., & Zhang, Z. (2021) · ACS Nano · doi:10.1021/acsnano.1c00033 · Cited by 108
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Saeed, M., Chen, F., Ye, J., Shi, Y., Lammers, T., Geest, B. G. D., Xu, Z. P., & Yu, H. (2021) · Advanced Materials · doi:10.1002/adma.202008094 · Cited by 108
Liu, Y., Zhou, J., Li, Q., Li, L., Jia, Y., Geng, F., Zhou, J., & Yin, T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.019 · Cited by 102
Yang, Z., Wang, J., Ai, S., Sun, J., Mai, X., & Guan, W. (2019) · Theranostics · doi:10.7150/thno.36988 · Cited by 102
“Hypoxia is also recognized as a dangerous factor that can cause tumor metastasis and angiogenesis [3, 4].”
BackgroundZhang, J., & Scarcelli, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00457-2 · Cited by 117
Ren, Q., Yu, N., Wang, L., Wen, M., Geng, P., Jiang, Q., Li, M., & Chen, Z. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.01.050 · Cited by 101
KUROZUMI, A., KATO, M., GOTO, Y., MATSUSHITA, R., NISHIKAWA, R., OKATO, A., FUKUMOTO, I., ICHIKAWA, T., & SEKI, N. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3440 · Cited by 100
Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases
Lee, H., Jose, C. C., & Cuddapah, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.020 · Cited by 111
Shan, L., Zhou, X., Liu, X., Wang, Y., Su, D., Hou, Y., Yu, N., Yang, C., Liu, B., Gao, J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.010 · Cited by 100
Nanomaterials-based photosensitizers and delivery systems for photodynamic cancer therapy
Yu, X., Sui, S., Yuxuan, H., Yu, C., & Peng, Q. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212725 · Cited by 112
Chen, J., Chen, J., Huang, J., Li, Z., Gong, Y., Zou, B., Liu, X., Ding, L., Li, P., Zhu, Z., et al. (2019) · Aging · doi:10.18632/aging.102488 · Cited by 117
“A tumour microenvironment with a low O2 levels is a contributing factor in increased metastasis rates [17], poorer patient survival [18] and some drug resistance [19].”
BackgroundLiu, Y., Wu, J., Huang, W., Weng, S., Wang, B., Chen, Y., & Wang, H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02366-0 · Cited by 99
Cheng, X., He, L., Xu, J., Fang, Q., Lü, Y., Xue, Y., Wang, X., & Tang, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.035 · Cited by 99
Shi, R., Bao, X., Unger, K., Sun, J., Lu, S., Manapov, F., Wang, X., Belka, C., & Li, M. (2021) · Theranostics · doi:10.7150/thno.56202 · Cited by 119
“Hypoxia has a wide-ranging impact on various biological processes, such as metabolism, angiogenesis and metastasis [12, 44, 45].”
BackgroundTumor vessel co-option probed by single-cell analysis
Teuwen, L.-A. M. N., de Rooij, L. P. M. H., Cuypers, A., Rohlenová, K., Dumas, S. J., García‐Caballero, M., Meta, E., Amersfoort, J., Taverna, F., Becker, L. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109253 · Cited by 105
Alleviating hypoxia to improve cancer immunotherapy
Fan, P., Zhang, N., Candi, E., Agostini, M., Piacentini, M., Bernassola, F., Bove, P., Alessandro, M., Giuseppe, N., Valentina, R., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02869-2 · Cited by 104
“Additionally, the HIF-induced transcriptional program also leads to the secretion of growth factors, which serves as chemotactic signals, attracting and activating stromal cells, thereby further promoting cancer progression [33].”
BackgroundNew trends in guided nanotherapies for digestive cancers: A systematic review
Fernandes, E., Ferreira, J. A., Peixoto, A., Luís, L., Barroso, S., Sarmento, B. F. C. C., & Santos, L. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.003 · Cited by 114
Zhang, C., Xia, D., Liu, J., Huo, D., Jiang, X., & Hu, Y. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000189 · Cited by 100
Qiu, M., Huang, K., Liu, Y., Yang, Y., Tang, H., Liu, X., Wang, C., Chen, H., Xiong, Y., Zhang, J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0144-6 · Cited by 102
Gupta, K., & Burns, T. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00503 · Cited by 106
Hao, X., Ren, Y., Feng, M., Wang, Q., & Wang, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111798 · Cited by 106
Metal peroxides for cancer treatment
He, J., Fu, L.-H., Qi, C., Lin, J., & Huang, P. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.026 · Cited by 93
“However, the rapid proliferation of cancer cells resulted the supply and consumption of oxygen (O2) unbalanced, combined with the abnormal structure and function of tumor blood vessels, made hypoxia the most prominent feature of tumor microenvironment (TME) [6,7].”
BackgroundCancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
Solimando, A. G., Summa, S. D., Vacca, A., & Ribatti, D. (2020) · Cancers · doi:10.3390/cancers12113380 · Cited by 98
“Moreover, insufficient oxygen supply influences ECM remodeling and stiffness [179], further halting the susceptibility to chemotherapy and radiation therapy [180].”
BackgroundHoffmann, C., Mao, X., Brown-Clay, J., Moreau, F., Al Absi, A., Wurzer, H., Sousa, B., Schmitt, F., Berchem, G., Janji, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28637-x · Cited by 92
Sistigu, A., Modugno, F. D., Manic, G., & Nisticò, P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.008 · Cited by 111
Lappano, R., Talia, M., Cirillo, F., Rigiracciolo, D. C., Scordamaglia, D., Guzzi, R., Miglietta, A., Francesco, E. M. D., Belfiore, A., Sims, A. H., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01667-y · Cited by 102
Photoacoustic imaging as a tool to probe the tumour microenvironment
Brown, E. L., Brunker, J., & Bohndiek, S. E. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039636 · Cited by 92
“1), are linked to poor patient prognosis (Gilkes et al., 2014).”
BackgroundInfluentialCancer biology as revealed by the research autopsy
Iacobuzio–Donahue, C. A., Michael, C., Baez, P., Kappagantula, R. L., Hooper, J. E., & Hollman, T. J. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0199-4 · Cited by 94
Obesity, sleep apnea, and cancer
Almendros, I., Martínez‐García, M. Á., Farré, R., & Gozal, D. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0549-z · Cited by 96
“Indeed, it increases the production of matrix proteases facilitating the degradation of the membrane that separates the tumor from surrounding tissues and enhances the formation of aligned collagen fiber tracks providing a better pathway for cell invasion and extravasation [99].”
BackgroundZheng, S., Zou, Y., Liang, J., Xiao, W., Yang, A., Meng, T., Lu, S., Luo, Z.-B., & Xie, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12747 · Cited by 100
Sun, J., Wang, J., Hu, W., Wang, Y., Zhang, Q., Hu, X., Chou, T., Zhang, B., Gallaro, C., Halloran, M., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02528 · Cited by 92
Zhang, F., Guo, J., Yu, S., Zheng, Y., Duan, M., Zhao, L., Wang, Y., Yang, Z., & Jiang, X. (2024) · 癌症:英文版 · doi:10.1002/cac2.12591 · Cited by 112
“Excessive hypoxia in tumor tissues disrupts the balance in the microenvironment, resulting in the formation of a hypoxic, hypoglycemic, and acidic TME that promotes tumor development [180].”
BackgroundPrivat‐Maldonado, A., Bengtson, C., Razzokov, J., Smits, E., & Bogaerts, A. (2019) · Cancers · doi:10.3390/cancers11121920 · Cited by 91
Metadata
- Authors
- Gilkes, D. M., Semenza, G. L., & Wirtz, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wirtz, Denis
- Venue
- Nature Reviews Cancer
- Published
- 2014-05-15
- Volume
- 14
- Issue
- 6
- Pages
- 430-439
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4283800
- OpenAlex
- W2069518226
- Cited by
- 1,520
- References
- 209
- Citations by year
- 2026: 99 · 2025: 129 · 2024: 149 · 2023: 151 · 2022: 175 · 2021: 192 · 2020: 164 · 2019: 132 · 2018: 106 · 2017: 95 · 2016: 75 · 2015: 41 · 2014: 9
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA143868, R01CA174388, K99CA181352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tumor hypoxia, extracellular matrix, tumour metastasis, tumor microenvironment, stromal cells, tumor cell motility, tumor cell proliferation
- MeSH terms
- Hypoxia, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.